Cell Therapeutics, Inc. Shares Fall After Going-concern Doubt; Company Needs to Raise Additional Funds

Reuters -- Shares of Cell Therapeutics fell 10 percent before the bell Monday, after the company said late Friday that its auditors had expressed "substantial doubt" about its ability to continue as a going concern.